438 related articles for article (PubMed ID: 24909889)
1. Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1.
Crouse J; Bedenikovic G; Wiesel M; Ibberson M; Xenarios I; Von Laer D; Kalinke U; Vivier E; Jonjic S; Oxenius A
Immunity; 2014 Jun; 40(6):961-73. PubMed ID: 24909889
[TBL] [Abstract][Full Text] [Related]
2. Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity.
Xu HC; Grusdat M; Pandyra AA; Polz R; Huang J; Sharma P; Deenen R; Köhrer K; Rahbar R; Diefenbach A; Gibbert K; Löhning M; Höcker L; Waibler Z; Häussinger D; Mak TW; Ohashi PS; Lang KS; Lang PA
Immunity; 2014 Jun; 40(6):949-60. PubMed ID: 24909887
[TBL] [Abstract][Full Text] [Related]
3. A stay of execution: type I interferons pardon T cells from death by natural killers.
Kahan SM; Zajac AJ
Immunity; 2014 Jun; 40(6):861-2. PubMed ID: 24950208
[TBL] [Abstract][Full Text] [Related]
4. NK cells negatively regulate CD8 T cells via natural cytotoxicity receptor (NCR) 1 during LCMV infection.
Pallmer K; Barnstorf I; Baumann NS; Borsa M; Jonjic S; Oxenius A
PLoS Pathog; 2019 Apr; 15(4):e1007725. PubMed ID: 30995287
[TBL] [Abstract][Full Text] [Related]
5. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
Bukowski JF; Welsh RM
J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
[TBL] [Abstract][Full Text] [Related]
6. Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection.
Zhou S; Cerny AM; Fitzgerald KA; Kurt-Jones EA; Finberg RW
J Virol; 2012 Oct; 86(20):11254-65. PubMed ID: 22875973
[TBL] [Abstract][Full Text] [Related]
7. NK cell-intrinsic FcεRIγ limits CD8+ T-cell expansion and thereby turns an acute into a chronic viral infection.
Duhan V; Hamdan TA; Xu HC; Shinde P; Bhat H; Li F; Al-Matary Y; Häussinger D; Bezgovsek J; Friedrich SK; Hardt C; Lang PA; Lang KS
PLoS Pathog; 2019 Jun; 15(6):e1007797. PubMed ID: 31220194
[TBL] [Abstract][Full Text] [Related]
8. The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium.
Satoh-Takayama N; Dumoutier L; Lesjean-Pottier S; Ribeiro VS; Mandelboim O; Renauld JC; Vosshenrich CA; Di Santo JP
J Immunol; 2009 Nov; 183(10):6579-87. PubMed ID: 19846871
[TBL] [Abstract][Full Text] [Related]
9. The NK receptor KLRG1 is dispensable for virus-induced NK and CD8+ T-cell differentiation and function in vivo.
Gründemann C; Schwartzkopff S; Koschella M; Schweier O; Peters C; Voehringer D; Pircher H
Eur J Immunol; 2010 May; 40(5):1303-14. PubMed ID: 20201037
[TBL] [Abstract][Full Text] [Related]
10. IRF9 Prevents CD8
Huber M; Suprunenko T; Ashhurst T; Marbach F; Raifer H; Wolff S; Strecker T; Viengkhou B; Jung SR; Obermann HL; Bauer S; Xu HC; Lang PA; Tom A; Lang KS; King NJC; Campbell IL; Hofer MJ
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878077
[TBL] [Abstract][Full Text] [Related]
11. The Variable Genomic NK Cell Receptor Locus Is a Key Determinant of CD4+ T Cell Responses During Viral Infection.
Raynor J; Lin A; Hummel SA; Lampe K; Jordan M; Hoebe K; Hildeman DA
Front Immunol; 2020; 11():197. PubMed ID: 32153566
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
[TBL] [Abstract][Full Text] [Related]
13. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus.
Bukowski JF; Biron CA; Welsh RM
J Immunol; 1983 Aug; 131(2):991-6. PubMed ID: 6190947
[TBL] [Abstract][Full Text] [Related]
14. Type I IFN substitutes for T cell help during viral infections.
Wiesel M; Kratky W; Oxenius A
J Immunol; 2011 Jan; 186(2):754-63. PubMed ID: 21160039
[TBL] [Abstract][Full Text] [Related]
15. Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor.
Zajac AJ; Vance RE; Held W; Sourdive DJ; Altman JD; Raulet DH; Ahmed R
J Immunol; 1999 Nov; 163(10):5526-34. PubMed ID: 10553080
[TBL] [Abstract][Full Text] [Related]
16. Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1.
Halfteck GG; Elboim M; Gur C; Achdout H; Ghadially H; Mandelboim O
J Immunol; 2009 Feb; 182(4):2221-30. PubMed ID: 19201876
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus Vector Vaccination Impacts NK Cell Rheostat Function following Lymphocytic Choriomeningitis Virus Infection.
Blass E; Aid M; Martinot AJ; Larocca RA; Kang ZH; Badamchi-Zadeh A; Penaloza-MacMaster P; Reeves RK; Barouch DH
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514912
[TBL] [Abstract][Full Text] [Related]
18. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon.
Le Bon A; Etchart N; Rossmann C; Ashton M; Hou S; Gewert D; Borrow P; Tough DF
Nat Immunol; 2003 Oct; 4(10):1009-15. PubMed ID: 14502286
[TBL] [Abstract][Full Text] [Related]
19. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense.
Satoh-Takayama N; Vosshenrich CA; Lesjean-Pottier S; Sawa S; Lochner M; Rattis F; Mention JJ; Thiam K; Cerf-Bensussan N; Mandelboim O; Eberl G; Di Santo JP
Immunity; 2008 Dec; 29(6):958-70. PubMed ID: 19084435
[TBL] [Abstract][Full Text] [Related]
20. Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1.
Glasner A; Ghadially H; Gur C; Stanietsky N; Tsukerman P; Enk J; Mandelboim O
J Immunol; 2012 Mar; 188(6):2509-15. PubMed ID: 22308311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
